<DOC>
	<DOCNO>NCT01241864</DOCNO>
	<brief_summary>The purpose study learn safety islet transplantation perform kidney transplantation , may provide normal control blood sugar without need insulin shot . Islets special cluster cell within pancreas produce insulin . These cell obtain cadaver ( non-living ) donor give subject vein .</brief_summary>
	<brief_title>Islet Transplantation Type 1 Diabetic Kidney Allograft</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Male female subject age 18 68 year . Subjects able provide write informed consent comply procedure study protocol . Clinical history compatible T1D disease onset &lt; 40 year age insulindependence &gt; 5 year time enrollment , sum subject age insulin dependent diabetes duration &gt; 28 . Absent stimulate cpeptide ( &lt; 0.3 ng/mL ) response MMTT [ Boost® 6 mL/kg body weight ( BW ) maximum 360 mL ; another product equivalent caloric nutrient content may substitute Boost® ] measure 60 90 min start consumption . Subjects &gt; 3 month postrenal transplant take appropriate calcineurin inhibitor ( CNI ) base maintenance immunosuppression ( [ tacrolimus alone conjunction sirolimus , mycophenolate mofetil , myfortic , azathioprine ; cyclosporine conjunction sirolimus , mycophenolate mofetil , myfortic ] ± Prednisone &lt; 10 mg/day ) subject receive islet transplant within 72hours kidney transplantation ( islet kidney donor ) Stable renal function define creatinine one third great average creatinine determination perform 3 previous month prior islet transplantation , rejection , obstruction infection rule . Weight 90 kg body mass index ( BMI ) &gt; 30 kg/m2 . Insulin requirement &gt; 1.0 IU/kg/day &lt; 15 U/day . Other ( nonkidney ) organ transplant except prior fail pancreatic graft graft fail within first two week due thrombosis , follow pancreatectomy ; pancreas transplant occur 6 month prior enrollment . Untreated unstable proliferative diabetic retinopathy . Blood Pressure : SBP &gt; 160 mmHg DBP &gt; 100 mmHg despite treatment antihypertensive agent . Calculated GFR &lt; 40 mL/min/1.73 m2 use subject 's measure serum creatinine Chronic Kidney Disease Epidemiology Collaboration ( CKDEPI ) equation [ 1 ] . Strict vegetarian ( vegan ) exclude estimate GFR &lt; 35 mL/min/1.73 m2 Proteinuria ( albumin/ creatinine ratio ACr &gt; 300mg/g ) new onset since kidney transplantation . Either Class I Class II panelreactive antiHLA antibody &gt; 50 % . Subjects either Class I Class II panel reactive antiHLA antibody &gt; 50 % exclude follow detect : Positive crossmatch , Islet donordirected antiHLA antibody detect Luminex Single Antigen/specificity bead assay include weakly reactive antibody would detect flow crossmatch , Antibodies renal donor ( i.e . presume de novo ) . For female subject : Positive pregnancy test , presently breastfeed , unwillingness use effective contraceptive measure duration study 4 month discontinuation . For male subject : intent procreate duration study within 4 month discontinuation unwillingness use effective measure contraception . Oral contraceptive , Norplant® , DepoProvera® , barrier device spermicide acceptable contraceptive method ; condom use alone acceptable . Presence history active infection include hepatitis B , hepatitis C , HIV , tuberculosis ( TB ) . Subjects laboratory evidence active infection exclude even absence clinical evidence active infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>